Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply
Gespeichert in:
| Veröffentlicht in: | Pharmacotherapy 2006, Vol.26 (7), p.1049-1050 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1050 |
|---|---|
| container_issue | 7 |
| container_start_page | 1049 |
| container_title | Pharmacotherapy |
| container_volume | 26 |
| creator | KRANTZ, Mori J IRONS, Brian K GREENE, R. Shane MAZZOLINI, Timothy EDWARDS, Krystal SLEEPER, Rebecca |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_17924243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17924243</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_179242433</originalsourceid><addsrcrecordid>eNqNjMFqwkAURQepYFr7D28jXQVmxtiom1JE0b17eU0m-nTMhPdmCvr1ZuEHuDpwOPcOVGbm5SxfGFO8qUzbssy11vORehc5a23Nd2EzRbtr56nCSKEVCA3EE-E9eKqpdXUvHSRxgG0NFXIv_lGq5JGBSS6whJ0ARUDvAf9Civ3egaQj8g_8pngK_CXArvO3sRo26MV9PvmhJpv1frXNu_4RfcPYViSHjumKfDuYcmELW0ynr3YPDQ1LSQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply</title><source>Access via Wiley Online Library</source><creator>KRANTZ, Mori J ; IRONS, Brian K ; GREENE, R. Shane ; MAZZOLINI, Timothy ; EDWARDS, Krystal ; SLEEPER, Rebecca</creator><creatorcontrib>KRANTZ, Mori J ; IRONS, Brian K ; GREENE, R. Shane ; MAZZOLINI, Timothy ; EDWARDS, Krystal ; SLEEPER, Rebecca</creatorcontrib><identifier>ISSN: 0277-0008</identifier><identifier>EISSN: 1875-9114</identifier><identifier>CODEN: PHPYDQ</identifier><language>eng</language><publisher>Boston, MA: Pharmacotherapy</publisher><subject>Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; General and cellular metabolism. Vitamins ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Pharmacotherapy, 2006, Vol.26 (7), p.1049-1050</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,4025</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17924243$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>KRANTZ, Mori J</creatorcontrib><creatorcontrib>IRONS, Brian K</creatorcontrib><creatorcontrib>GREENE, R. Shane</creatorcontrib><creatorcontrib>MAZZOLINI, Timothy</creatorcontrib><creatorcontrib>EDWARDS, Krystal</creatorcontrib><creatorcontrib>SLEEPER, Rebecca</creatorcontrib><title>Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply</title><title>Pharmacotherapy</title><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0277-0008</issn><issn>1875-9114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjMFqwkAURQepYFr7D28jXQVmxtiom1JE0b17eU0m-nTMhPdmCvr1ZuEHuDpwOPcOVGbm5SxfGFO8qUzbssy11vORehc5a23Nd2EzRbtr56nCSKEVCA3EE-E9eKqpdXUvHSRxgG0NFXIv_lGq5JGBSS6whJ0ARUDvAf9Civ3egaQj8g_8pngK_CXArvO3sRo26MV9PvmhJpv1frXNu_4RfcPYViSHjumKfDuYcmELW0ynr3YPDQ1LSQ</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>KRANTZ, Mori J</creator><creator>IRONS, Brian K</creator><creator>GREENE, R. Shane</creator><creator>MAZZOLINI, Timothy</creator><creator>EDWARDS, Krystal</creator><creator>SLEEPER, Rebecca</creator><general>Pharmacotherapy</general><scope>IQODW</scope></search><sort><creationdate>2006</creationdate><title>Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply</title><author>KRANTZ, Mori J ; IRONS, Brian K ; GREENE, R. Shane ; MAZZOLINI, Timothy ; EDWARDS, Krystal ; SLEEPER, Rebecca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_179242433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KRANTZ, Mori J</creatorcontrib><creatorcontrib>IRONS, Brian K</creatorcontrib><creatorcontrib>GREENE, R. Shane</creatorcontrib><creatorcontrib>MAZZOLINI, Timothy</creatorcontrib><creatorcontrib>EDWARDS, Krystal</creatorcontrib><creatorcontrib>SLEEPER, Rebecca</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KRANTZ, Mori J</au><au>IRONS, Brian K</au><au>GREENE, R. Shane</au><au>MAZZOLINI, Timothy</au><au>EDWARDS, Krystal</au><au>SLEEPER, Rebecca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply</atitle><jtitle>Pharmacotherapy</jtitle><date>2006</date><risdate>2006</risdate><volume>26</volume><issue>7</issue><spage>1049</spage><epage>1050</epage><pages>1049-1050</pages><issn>0277-0008</issn><eissn>1875-9114</eissn><coden>PHPYDQ</coden><cop>Boston, MA</cop><pub>Pharmacotherapy</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0277-0008 |
| ispartof | Pharmacotherapy, 2006, Vol.26 (7), p.1049-1050 |
| issn | 0277-0008 1875-9114 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_17924243 |
| source | Access via Wiley Online Library |
| subjects | Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance General and cellular metabolism. Vitamins Medical sciences Pharmacology. Drug treatments |
| title | Implications of thiazolidinedione use and cardiovascular risk : Is it all about the sugar? Author's reply |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T11%3A40%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implications%20of%20thiazolidinedione%20use%20and%20cardiovascular%20risk%20:%20Is%20it%20all%20about%20the%20sugar?%20Author's%20reply&rft.jtitle=Pharmacotherapy&rft.au=KRANTZ,%20Mori%20J&rft.date=2006&rft.volume=26&rft.issue=7&rft.spage=1049&rft.epage=1050&rft.pages=1049-1050&rft.issn=0277-0008&rft.eissn=1875-9114&rft.coden=PHPYDQ&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E17924243%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |